Brewin Dolphin LTD Pds Biotechnology Corp Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Nov 09, 2023
BUY
$4.35 - $12.86 $6,524 - $19,290
1,500 Added 32.26%
6,150 $77.2 Million
Q1 2021

Nov 09, 2023
BUY
$2.28 - $6.81 $3,191 - $9,534
1,400 Added 43.08%
4,650 $21.2 Million
Q3 2020

Nov 09, 2023
BUY
$1.67 - $4.67 $5,427 - $15,177
3,250 New
3,250 $7.57 Million

Others Institutions Holding PDSB

# of Institutions
59
Shares Held
4.22M
Call Options Held
170K
Put Options Held
6.7K
View Full List

About PDS Biotechnology Corp

PDSB Quotes by TradingView
  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $35.6M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email